Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 5/20 | 0.60 |
| ▸ | CTSK | P43235 | 5/20 | 0.60 |
| ▸ | CTSL | P07711 | 4/20 | 0.60 |
| ▸ | CTSB | P07858 | 3/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.55 |
| ▸ | TACR1 | P25103 | 2/20 | 0.54 |
| ▸ | MMP8 | P22894 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | GLS | O94925 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2120048 | 1.00 | CTSS (0.60) | CTSSCTSKCTSLCTSBGAA | |
| SCHEMBL993635 | 0.93 | CTSS (0.56) | CTSSCTSKCTSLCTSBGAA | |
| SCHEMBL7762796 | 0.89 | CTSL (0.74) | CTSSCTSKCTSLCTSBGAA | |
| SCHEMBL7348355 | 0.88 | FNTA (0.61) | CTSSCTSKCTSLCTSBGAA | |
| SCHEMBL7540842 | 0.88 | CTSS (0.58) | CTSSCTSKCTSLCTSBTACR1 | |
| SCHEMBL13584223 | 0.88 | MMP8 (0.56) | CTSSCTSKCTSLCTSBGAA | |
| SCHEMBL13584226 | 0.88 | MMP8 (0.56) | CTSSCTSKCTSLCTSBGAA | |
| SCHEMBL7140209 | 0.88 | CASP1 (0.60) | CTSSCTSKCTSLCTSBGAA | |
| SCHEMBL992273 | 0.88 | CTSS (0.50) | CTSSCTSKCTSLCTSBGAA | |
| SCHEMBL9068032 | 0.86 | CTSS (0.57) | CTSSCTSKCTSLCTSBTACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130041180-A1 | PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE | MSN LABORATORIES PRIVATE LIMITED (IN) | 2013-02-14 | — | — | US | claimed |
| EP-2534127-A1 | PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE | MSN Laboratories Limited (IN) | 2012-12-19 | — | — | EP | claimed |
| WO-2011099033-A1 | PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE | MSN LABORATORIES LIMITED (IN) | 2011-08-18 | — | — | WO | claimed |
| US-20100240926-A1 | PROCESS FOR PREPARING (R)-N-BENZYL-2-(BENYLOXYCARBONYLAMINO)-3-METHOXYPROPIONAMIDE | PLIVA HRVATSKA D.O.O. (HR) | 2010-09-23 | — | — | US | claimed |
| EP-2444390-B1 | Process for producing Lacosamide | EUTICALS GMBH (DE) | 2017-02-01 | — | — | EP | disclosed |
| EP-2444390-B1 | Process for producing Lacosamide | EUTICALS GMBH (DE) | 2017-02-01 | — | — | EP | disclosed |
| US-20160031801-A1 | DEUTERATED 2-AMINO-3-HYDROXYPROPANOIC ACID DERIVATIVES | CONCERT PHARMACEUTICALS, INC. (US) | 2016-02-04 | — | — | US | disclosed |
| US-20160031801-A1 | DEUTERATED 2-AMINO-3-HYDROXYPROPANOIC ACID DERIVATIVES | CONCERT PHARMACEUTICALS, INC. (US) | 2016-02-04 | — | — | US | disclosed |
| US-9108902-B2 | Deuterated 2-amino-3-hydroxypropanoic acid derivatives | CONCERT PHARMACEUTICALS, INC. (US) | 2015-08-18 | — | — | US | disclosed |
| US-9108902-B2 | Deuterated 2-amino-3-hydroxypropanoic acid derivatives | CONCERT PHARMACEUTICALS, INC. (US) | 2015-08-18 | — | — | US | disclosed |
| US-8907132-B2 | Process for preparing (R)-2-acetamido-N-benzyl-3-methoxy-propionamide | MSN LABORATORIES PRIVATE LIMITED (IN) | 2014-12-09 | — | — | US | disclosed |
| US-8907132-B2 | Process for preparing (R)-2-acetamido-N-benzyl-3-methoxy-propionamide | MSN LABORATORIES PRIVATE LIMITED (IN) | 2014-12-09 | — | — | US | disclosed |
| WO-2010107993-A3 | PROCESS FOR PREPARING (R)-7V-BENZYL-2- (BENYLOXYCARBONYLAMINO)-S-METHOXYPROPIONAMIDE | PLIVA HRVATSKA D.O.O. (HR) | 2010-11-04 | — | — | WO | disclosed |
| WO-2010107993-A2 | PROCESS FOR PREPARING (R)-7V-BENZYL-2- (BENYLOXYCARBONYLAMINO)-S-METHOXYPROPIONAMIDE | PLIVA HRVATSKA D.O.O. (HR) | 2010-09-23 | — | — | WO | disclosed |
| WO-2010107993-A2 | PROCESS FOR PREPARING (R)-7V-BENZYL-2- (BENYLOXYCARBONYLAMINO)-S-METHOXYPROPIONAMIDE | PLIVA HRVATSKA D.O.O. (HR) | 2010-09-23 | — | — | WO | disclosed |
| WO-2010107993-A2 | PROCESS FOR PREPARING (R)-7V-BENZYL-2- (BENYLOXYCARBONYLAMINO)-S-METHOXYPROPIONAMIDE | PLIVA HRVATSKA D.O.O. (HR) | 2010-09-23 | — | — | WO | disclosed |
| US-20100240926-A1 | PROCESS FOR PREPARING (R)-N-BENZYL-2-(BENYLOXYCARBONYLAMINO)-3-METHOXYPROPIONAMIDE | PLIVA HRVATSKA D.O.O. (HR) | 2010-09-23 | — | — | US | disclosed |
| US-20100240926-A1 | PROCESS FOR PREPARING (R)-N-BENZYL-2-(BENYLOXYCARBONYLAMINO)-3-METHOXYPROPIONAMIDE | PLIVA HRVATSKA D.O.O. (HR) | 2010-09-23 | — | — | US | disclosed |
| US-20100240926-A1 | PROCESS FOR PREPARING (R)-N-BENZYL-2-(BENYLOXYCARBONYLAMINO)-3-METHOXYPROPIONAMIDE | PLIVA HRVATSKA D.O.O. (HR) | 2010-09-23 | — | — | US | disclosed |
| US-20100240926-A1 | PROCESS FOR PREPARING (R)-N-BENZYL-2-(BENYLOXYCARBONYLAMINO)-3-METHOXYPROPIONAMIDE | PLIVA HRVATSKA D.O.O. (HR) | 2010-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240926-A1 | PROCESS FOR PREPARING (R)-N-BENZYL-2-(BENYLOXYCARBONYLAMINO)-3-METHOXYPROPIONAMIDE | NAAA, MME, CA2 | CTSS 414/4885CTSK 1666/4885CTSL 795/4885 |
| US-20160031801-A1 | DEUTERATED 2-AMINO-3-HYDROXYPROPANOIC ACID DERIVATIVES | GRIN3A, GRIK5, GRIN2A | CTSS 4649/4885CTSK 4527/4885CTSL 4486/4885 |
| US-20130041180-A1 | PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE | AMY1A, PTMA, NAAA | CTSS 2565/4885CTSK 3441/4885CTSL 2798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.